TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, we found that pre-treatment with BMP2/4 and TGF-β1 had inhibitory effects on cell proliferation; however, the combinational treatment with miR-155 mimics resulted in a higher proliferation rate in CD34+ CML cells.